Isolation of interferon-resistant variants of friend erythroleukemia cells: Effects of interferon and ouabain

Elisabetta Affabris, C Jemma, Giovanni Battista Rossi

Virology

Autoimmune DiseaseFriend Erythroleukemia CellsImmunologyHematologyBlood Cell +3

Obligatory role of IFN- <i>gamma</i> in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.

Mirella Giovarelli, Angela Santoni, C Jemma, +5

The Journal of Immunology

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

R. Foà, M Giovarelli, C Jemma, +5

Blood

2–5A synthetase activity does not increase in interferon-resistant friend leukemia cell variants treated with α/β interferon despite the presence of high-affinity interferon receptor sites

Elisabetta Affabris, G. Romeo, Filippo Belardelli, +4

Virology

Synthetase ActivityImmunologyAntisense Therapyα/β InterferonMedicine +3

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

G Cortesina, Antonella De Stefani, E Galeazzi, +4

British Journal of Cancer

Cancer ResearchHigh DoseMedicineImmunologyRecombinant Interleukin 2 +10

Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Guido Valente, Paola Secchiero, Paolo Lusso, +6

PubMed

Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma.

Piero Musiani, de Campora E, Salvatore Valitutti, +7

PubMed

Natural Il-2MedicineHistopathologyPathologyAdvanced Primary Head +13

Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice.

G Forni, Tiziana Musso, C Jemma, +3

The Journal of Immunology

ImmunologyDaily Peptide InjectionsImmunologic MechanismImmune SystemImmunotherapy +14

The Effect of Preoperative Local Interleukin-2 (IL-2) Injections in Patients with Head and Neck Squamous Cell Carcinoma: An Immunological Study

G Cortesina, Antonella De Stefani, E Galeazzi, +7

Acta Oto-Laryngologica

ImmunologyImmunoeditingPathologyImmunotherapyImmunological Study +18

Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.

Guido Valente, De Stefani A, C Jemma, +5

PubMed